Covid-19: The daily dose (June 11, 2021)

PT Jyothi Datta Mumbai | Updated on June 11, 2021

We curate for you all the Covid-19-related developments and stories of the day worth reading

The country’s Covid-19 mortality numbers saw a steep increase yesterday because of a revision from Bihar. But that’s not necessarily a bad thing.

Here’s why:

As another home-use kit gets approved, will it keep people from rushing to testing Centres or are the high false negatives a draw back? Experts weigh in.

Meanwhile, Tamil Nadu stays cautious, extends its lockdown.

In a worrying find, reinfections are seen among healthcare workers in the Capital. Though the study had limited scope, it calls for a larger investigation.

And the alliances on Covid-drugs continues, this time on Merck drug molnupiravir.

The Biden administration’s commitment to supply Pfizer vaccines was announced as expected. About 200 million of the 500 million will be delivered by later this year.

As the need for masks looks unlikely to go away, just yet – here’s one hybrid, washable model.

Published on June 11, 2021

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

  1. Comments will be moderated by The Hindu Business Line editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.